The live educational activity is designed to address relevant practice gaps for FPs who manage people with diabetes, including CV risk factor assessment, current standards of care for CV risk reduction in diabetes, recent clinical trial data supporting the use of sodium glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) therapies for CV risk reduction in people with diabetes, and key messages for effective patient/caregiver education and shared decision making in diabetes care.